Skip to main content
Premium Trial:

Request an Annual Quote

Teranode Raises $9.5M in Series B Round

NEW YORK, Sept. 12 (GenomeWeb News) - Teranode has closed a $9.5-million Series B financing round, the Seattle-based company said today.

 

Cargill Ventures and Trident Capital led the investment and were joined by prior investors Ignition Partners and WRF Capital.

 

Teranode plans to use the funding to expand sales and consulting in "major biopharma hubs" in North America and Europe. It will also add to its product to support translational medicine and establish a program for technology partnerships.

 

Teranode has an informatics platform, XDA, that combines computational chemistry and biology with lab data to automate tasks. Including the Series B round, the company has raised $12.1 million in total.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.